These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 8710138)

  • 1. Tissue protection by anti-ischemic drugs.
    Nolte D; Messmer K
    Minerva Cardioangiol; 1995; 43(11-12):485-91. PubMed ID: 8710138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microvascular in vivo assessment of reperfusion injury: significance of prostaglandin E(1) and I(2) in postischemic "no-reflow" and "reflow-paradox".
    Tauber S; Menger MD; Lehr HA
    J Surg Res; 2004 Jul; 120(1):1-11. PubMed ID: 15172184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Microcirculation of skeletal muscle after ischemia and reperfusion].
    Menger MD; Messmer K
    Wien Med Wochenschr; 1993; 143(7-8):148-58. PubMed ID: 8379164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pentoxifylline reduces venular leukocyte adherence ("reflow paradox") but not microvascular "no reflow" in hepatic ischemia/reperfusion.
    Müller JM; Vollmar B; Menger MD
    J Surg Res; 1997 Jul; 71(1):1-6. PubMed ID: 9271270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathomechanisms of ischemia-reperfusion injury as the basis for novel preventive strategies: is it time for the introduction of pleiotropic compounds?
    Menger MD; Vollmar B
    Transplant Proc; 2007 Mar; 39(2):485-8. PubMed ID: 17362764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.
    Ferdinandy P; Schulz R; Baxter GF
    Pharmacol Rev; 2007 Dec; 59(4):418-58. PubMed ID: 18048761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Trimetazidine and cardioprotection during ischemia-reperfusion].
    Barsotti A; Di Napoli P
    Ital Heart J; 2004 Mar; 5 Suppl 2():29S-36S. PubMed ID: 15074775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sivelestat reduces myocardial ischemia and reperfusion injury in rat hearts even when administered after onset of myocardial ischemia.
    Kambe M; Bessho R; Fujii M; Ochi M; Shimizu K
    Interact Cardiovasc Thorac Surg; 2009 Jun; 8(6):629-34. PubMed ID: 19279053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The no-reflow phenomenon: epidemiology, pathophysiology, and therapeutic approach.
    Alfayoumi F; Srinivasan V; Geller M; Gradman A
    Rev Cardiovasc Med; 2005; 6(2):72-83. PubMed ID: 15976730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary endothelial cells: a target of ischemia reperfusion and its treatment?
    Laude K; Richard V; Thuillez C
    Arch Mal Coeur Vaiss; 2004 Mar; 97(3):250-4. PubMed ID: 15106748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Capillary dysfunction in striated muscle ischemia/reperfusion: on the mechanisms of capillary "no-reflow".
    Menger MD; Rücker M; Vollmar B
    Shock; 1997 Jul; 8(1):2-7. PubMed ID: 9249906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Reperfusion and postconditioning in acute ST segment elevation myocardial infarction. A new paradigm for the treatment of acute myocardial infarction. From bench to bedside?].
    Lupi Herrera E; Gaspar J; González Pacheco H; Martínez Sánchez C; Pastelín Hernández G; Luna Ortiz P; Chávez Cosio E
    Arch Cardiol Mex; 2006; 76 Suppl 4():S76-101. PubMed ID: 17469337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in coronary vessel resistance during postischemic reperfusion and effectiveness of nitroglycerin.
    Kalweit GA; Schipke JD; Godehardt E; Gams E
    J Thorac Cardiovasc Surg; 2001 Nov; 122(5):1011-8. PubMed ID: 11689808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Coronary endothelial dysfunction after ischemia-reperfusion: mechanisms and possibilities for protection].
    Laude K; Thuillez C; Richard V
    Therapie; 2001; 56(5):589-93. PubMed ID: 11806298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perfluorocarbon in microcirculation during ischemia reperfusion.
    Cabrales P; Tsai AG; Intaglietta M
    J Am Coll Surg; 2007 Feb; 204(2):225-35. PubMed ID: 17254926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronary endothelial dysfunction after ischemia and reperfusion and its prevention by ischemic preconditioning.
    Pagliaro P; Chiribiri A; Mancardi D; Rastaldo R; Gattullo D; Losano G
    Ital Heart J; 2003 Jun; 4(6):383-94. PubMed ID: 12898803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury.
    Vinten-Johansen J
    Cardiovasc Res; 2004 Feb; 61(3):481-97. PubMed ID: 14962479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo analysis of microcirculation following closed soft-tissue injury.
    Schaser KD; Vollmar B; Menger MD; Schewior L; Kroppenstedt SN; Raschke M; Lübbe AS; Haas NP; Mittlmeier T
    J Orthop Res; 1999 Sep; 17(5):678-85. PubMed ID: 10569476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute endotoxemia protracts leukocyte / endothelium interaction after local ischemia and reperfusion in striated muscle.
    Galla TJ; Borges J; Kawasaki K; Lehr H; Messmer K
    Eur J Med Res; 2000 Mar; 5(3):93-100. PubMed ID: 10756162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effects of ITF 296 in the isolated rabbit heart subjected to global ischemia.
    Rossoni G; Berti F; Bernareggi M; Villa L; Agozzino S; Cereda R; Giuliani P; Mizrahi J
    J Cardiovasc Pharmacol; 1995; 26 Suppl 4():S44-52. PubMed ID: 8839226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.